Systemic immune activation is a striking consequence of HIV‐1 infection. Even in
virologically suppressed patients, some hyperactivity of the immune system and even of the …

Dendritic cells (DCs) function as a link between innate and adaptive immune responses.
Retroviruses HIV-1 and HTLV-1 modulate DCs to their advantage and utilize them to …

Human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I) are
two retroviruses that attack the immune cells and impair their functions. Both HIV and HTLV-I …

Aim To perform a systematic review to describe the available findings on clinical outcomes
in HIV-1 and HTLV-1/HTLV-2 co-infected individuals since 1995. Design This Systematic …

Las enfermedades infecciosas desatendidas (EID) afectan a más de mil millones de
personas en el mundo, y están asociadas con la pobreza, el aislamiento geográfico de las …

Surveillance of emerging viral variants is critical to ensuring that blood screening and
diagnostic tests detect all infections regardless of strain or geographic location. In this study …

In the literature, a great number of HIV and HTLV-I mono-infection models has been
formulated and analyzed. However, the within-host dynamics of HIV/HTLV-I co-infection has …

The human T-lymphotropic virus (HTLV) is part of the group of retroviruses that share similar
routes of transmission to the human immunodeficiency virus (HIV). Coinfection of these …

Human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I) are
two retroviruses that attack the CD4^+ CD4+ T cells and impair their functions. Both HIV and …

Worldwide, Human T-lymphtropic virus-1 and 2 (HTLV-1 and 2) infects approximately more
than 10 million people, mostly occurring in hyperendemic areas such as the region of Latin …